Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy.

R M Kacmarek1

  • 1Department of Anesthesia, Harvard Medical School, Boston, Massachusetts, USA.

Respiratory Care Clinics of North America
|April 3, 2002
PubMed
Summary
This summary is machine-generated.

Combining therapies like high-frequency ventilation (HFV) and extracorporeal membrane oxygenation (ECMO) for cytomegalovirus (CMV) shows promise. While individual treatments have limited success, their combined use may improve patient outcomes, warranting further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EPISYNC study: predictors of patient-ventilator asynchrony in a prospective cohort of patients under invasive mechanical ventilation - study protocol.

BMJ open·2019
Same author

Continuous non-invasive cardiac output monitoring during exercise: validation of electrical cardiometry with Fick and thermodilution methods.

British journal of anaesthesia·2016
Same author

Is esophageal pressure monitoring essential for the most critically ill?

Minerva anestesiologica·2015
Same author

Efficacy of ventilation through a customized novel cuffed airway exchange catheter: a tracheal/lung model study.

British journal of anaesthesia·2014
Same author

It does not matter whether you are an elephant or a shrew: all mammals' tidal volumes are similarly scaled!

Minerva anestesiologica·2014
Same author

Management of refractory hypoxemia in ARDS.

Minerva anestesiologica·2013
Same journal

Indirect calorimetry: relevance to patient outcome.

Respiratory care clinics of North America·2006
Same journal

Indirect calorimetry: applications in practice.

Respiratory care clinics of North America·2006
Same journal

Strategies to prevent aspiration-related pneumonia in tube-fed patients.

Respiratory care clinics of North America·2006
Same journal

Feeding the critically ill obese patient: the role of hypocaloric nutrition support.

Respiratory care clinics of North America·2006
Same journal

Nutrition support for the long-term ventilator-dependent patient.

Respiratory care clinics of North America·2006
Same journal

A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome.

Respiratory care clinics of North America·2006
See all related articles

Area of Science:

  • Pediatric critical care medicine
  • Respiratory support modalities
  • Infectious disease management

Background:

  • Cytomegalovirus (CMV) infections pose significant challenges in critically ill patients.
  • Established treatment modalities like high-frequency ventilation (HFV), extracorporeal membrane oxygenation (ECMO), nitric oxide (NO), and partial liquid ventilation (PLV) have shown variable efficacy.
  • The optimal application and combination of these advanced respiratory support strategies for CMV require further investigation.

Purpose of the Study:

  • To evaluate the potential synergistic effects of combining various advanced respiratory support modalities for managing cytomegalovirus (CMV) infections.
  • To explore whether combined therapeutic approaches offer improved outcomes compared to individual modalities.
  • To identify the need for further research into optimal application and patient selection for combined therapies.

Related Experiment Videos

Main Methods:

  • Review and analysis of existing studies on HFV, ECMO, NO, and PLV in the context of CMV treatment.
  • Comparative assessment of outcomes reported for individual modalities versus their combined use.
  • Identification of gaps in current research regarding optimal protocols and patient populations.

Main Results:

  • Individually, HFV, ECMO, and PLV have not demonstrated statistically significant outcome improvements for CMV.
  • Nitric oxide (NO) has shown a statistically significant improvement in outcome, but only in a small, select patient group.
  • Preliminary findings suggest that combining these modalities may lead to a greater overall impact on patient outcomes than single-agent therapies.

Conclusions:

  • While not conclusive, the combined use of advanced respiratory support modalities for CMV is encouraging.
  • Further laboratory and clinical studies are essential to determine optimal application strategies and identify specific patient populations that benefit most from these combined therapies.
  • More research is needed to refine protocols and maximize the potential benefits of multimodal treatment approaches for CMV.